5692-97-7

Usage

Physical form

White, crystalline solid

Solubility

Soluble in water and organic solvents

Uses

Production of pharmaceuticals, reagent in organic chemistry, potential applications in the development of new materials and research purposes

Stability

Stable

Reactivity

Reactive, contributing to its wide range of potential uses.

InChI:InChI=1/C8H14O4/c1-3-8(4-2,7(11)12)5-6(9)10/h3-5H2,1-2H3,(H,9,10)(H,11,12)

Upstream product

• 875250-20-7 3,3-diethyl-4-oxo-valeric acid 
• 2840-68-8 3-ethyl-2,3-dicyano-valeric acid ethyl ester 
• 105-56-6 ethyl 2-cyanoacetate 
• 96-22-0 pentan-3-one 
• 100319-48-0 3,6-diethyl-octa-2,6-dien-4-yne 
• 859447-57-7 2,4,4-triethyl-3-methyl-cyclopent-2-enone 
• 34451-66-6 2-ethyl-2-hydroxybutanenitrile 
• 868-04-2 ethyl 2-cyano-3,3-diethylacrylate 
• 64-17-5 ethanol 

Downstream Products

• 168082-74-4 CGP 57698 
• 168082-87-9 4-[3-(7-benzyloxy-2-quinolinylmethoxy)phenylamino]-2,2-diethyl-4-oxobutanoic acid 
• 2840-69-9 3,3-diethyldihydrofuran-2,5-dione 
• 128312-51-6 (E)-4-[[3-[2-(4-cyclobutyl-2-thiazolyl)ethenyl]phenyl]amino]-2,2-diethyl-4-oxobutanoic acid 
• 1337926-33-6 3,3-diethyl-1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-dione 
• 1337926-34-7 1-{2-[4-(2-chlorophenyl)piperazin-1-yl]-2-oxoethyl}-3,3-diethylpyrrolidine-2,5-dione 
• 1034317-25-3 1-(2,4-dichlorophenylamino)-3,3-diethylpyrrolidine-2,5-dione 
• 1034317-23-1 1-(2-chlorophenylamino)-3,3-diethylpyrrolidine-2,5-dione 
• 1034317-26-4 1-(4-bromophenylamino)-3,3-diethylpyrrolidine-2,5-dione 
• 1034317-22-0 1-(4-methylphenylamino)-3,3-diethylpyrrolidine-2,5-dione 
• 1034317-24-2 1-(4-chlorophenylamino)-3,3-diethylpyrrolidine-2,5-dione 
• 397845-98-6 1-phenylamino-3,3-diethylpyrrolidine-2,5-dione 

Relevant academic research and scientific papers

Cycloalkylthiazoles

The invention relates to compounds of the formula: STR1 wherein R is hydrogen or lower alkyl, R1, R2, R3 and R4, independently, are hydrogen, lower alkyl, lower alkenyl, cycloalkyl or phenyl unsubstituted or substituted by up to 3 substituents independently selected from lower alkyl, lower alkoxy or halogen, or R1 and R2 taken together with the carbon atom are alkylene of 2 to 5 carbon atoms unsubstituted or substituted by lower alkyl, and n is an integer of from 0 to 3, and, when R1 is different from R2 and/or when R3 is different from R4, enantiomers, diastereomers and racemates thereof and, when R is hydrogen, salts thereof with pharmaceutically acceptable bases. The compounds of formula I and, when R is hydrogen, pharmaceutically exceptable salts thereof are useful as bronchopulmonary agents, for example, in the relief of asthma and allergic reactions.